Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Branislav Jeremić

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinical Lung Cancer|December 3, 2014
Standard treatment option in stage III non-small-cell lung cancer: case against trimodal therapy and consolidation drug therapyBranislav Jeremić
American Journal of Clinical Oncology|November 9, 2017
Induction Therapies Plus Surgery Versus Exclusive Radiochemotherapy in Stage IIIA/N2 Non-Small Cell Lung Cancer (NSCLC)Branislav Jeremić
American Journal of Clinical Oncology|June 10, 2009
Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapyBranislav Jeremić, Biljana Miličić
International Journal of Radiation Oncology, Biology, Physics|February 20, 2007
Influence of interfraction interval on local tumor control in patients with limited-disease small-cell lung cancer treated with radiochemotherapyBranislav Jeremić, Biljana Milićić
American Journal of Clinical Oncology|March 25, 2009
Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapyBranislav Jeremić, Biljana Milicić
American Journal of Clinical Oncology|June 6, 2008
Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapyBranislav Jeremić, Biljana Milicić
Cancer|January 4, 2008
From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancerBranislav Jeremić, Biljana Milicić
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2008
Influence of low-dose daily cisplatin on the distant metastasis-free survival of patients with locally advanced nonmetastatic head and neck cancer treated with radiation therapyBranislav Jeremić, Biljana Milicić
Cancer|June 22, 2011
Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 PatientsBranislav Jeremić, Biljana Miličić, Slobodan Milisavljevic
International Journal of Radiation Oncology, Biology, Physics|June 7, 2011
Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: single institution experience with 600 patientsBranislav Jeremić, Biljana Miličić, Slobodan Milisavljevic
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical Lung Cancer|December 3, 2014
Standard treatment option in stage III non-small-cell lung cancer: case against trimodal therapy and consolidation drug therapyBranislav Jeremić
American Journal of Clinical Oncology|November 9, 2017
Induction Therapies Plus Surgery Versus Exclusive Radiochemotherapy in Stage IIIA/N2 Non-Small Cell Lung Cancer (NSCLC)Branislav Jeremić
American Journal of Clinical Oncology|June 10, 2009
Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapyBranislav Jeremić, Biljana Miličić
International Journal of Radiation Oncology, Biology, Physics|February 20, 2007
Influence of interfraction interval on local tumor control in patients with limited-disease small-cell lung cancer treated with radiochemotherapyBranislav Jeremić, Biljana Milićić
American Journal of Clinical Oncology|March 25, 2009
Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapyBranislav Jeremić, Biljana Milicić
American Journal of Clinical Oncology|June 6, 2008
Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapyBranislav Jeremić, Biljana Milicić
Cancer|January 4, 2008
From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancerBranislav Jeremić, Biljana Milicić
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2008
Influence of low-dose daily cisplatin on the distant metastasis-free survival of patients with locally advanced nonmetastatic head and neck cancer treated with radiation therapyBranislav Jeremić, Biljana Milicić
Cancer|June 22, 2011
Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 PatientsBranislav Jeremić, Biljana Miličić, Slobodan Milisavljevic
International Journal of Radiation Oncology, Biology, Physics|June 7, 2011
Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: single institution experience with 600 patientsBranislav Jeremić, Biljana Miličić, Slobodan Milisavljevic
Pageof 3